In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
about
Isosteviol has beneficial effects on palmitate-induced α-cell dysfunction and gene expressionImpaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathyA K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans.Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes.Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cellsBinding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cellsThe Zone Diet phenomenon: a closer look at the science behind the claims.A reappraisal of the blood glucose homeostat which comprehensively explains the type 2 diabetes mellitus-syndrome X complex.The physiology of glucagon.Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas.Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.Insulin within islets is a physiologic glucagon release inhibitorHypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal nShort-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses.Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes.miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker developmentThe mechanisms that underlie glucose sensing during hypoglycaemia in diabetes.Insulin signaling in alpha cells modulates glucagon secretion in vivo.Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.Growth factor signalling in the regulation of α-cell fate.Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.Novel function of transthyretin in pancreatic alpha cells.Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells.Retrograde perfusion as a model for testing the relative effects of glucose versus insulin on the A cell.Adaptation of B and A cell function during prolonged glucose infusion in human subjects.Glucagon Secreting Cells Responds to Insulin Secretion In vitro Using Immunocytochemistry.AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat.
P2860
Q28481674-1C6AFC05-A198-4E84-B3FD-08B1B3D72836Q28577037-DA1FF0E2-B4EE-4B22-BDEB-FCE09A375407Q33284703-E47CBC3F-624B-4BF4-9087-4B0D8319626AQ33347638-7EF5573E-C163-4680-8311-4D9A5917D917Q33585517-8C7D71DF-A210-4CB6-86CA-35382BB7C60DQ33847832-04BAC03D-2E9F-47CA-8AD3-B4D4A5DC19BAQ34175254-4E7DC10F-CBC8-4140-B66F-C90A458F1DE3Q34193110-773D1123-D1FA-4BCB-B3BC-6CCB998E4783Q34419963-83813CFC-7612-4785-AA5F-21C372381C3BQ34545743-0BF71D89-7AEE-4DCD-84BA-508066B0B556Q34606880-FC721B44-13FC-4C2B-93CE-E7F2A5C429E8Q34623723-BD770C6B-BCBD-452C-A353-228F23A6974DQ34974852-E9C0BB80-50F2-4DE7-B581-F6E0756A77CCQ35208670-F4F3B26C-CFE2-42D4-8B54-C47482DBB6B1Q35916821-2BE77386-FA57-4F39-9062-2DC84D9A02F7Q36109086-20267FCA-0136-4DCC-B6F9-B0CCAE392E07Q36109279-4F1AE21B-F478-4DA5-9068-70D14C3FA86AQ37099116-E6CF6246-7D18-4234-A4FD-D7AC644DC4F9Q37223046-EB75D6FB-3563-4FB0-BD8E-2B4B5C2D42A4Q37345603-6875EEFE-E99D-4691-8212-FA5755763C1AQ37913500-F85BB26B-56E3-4666-8EC6-E57234F39FB4Q38297682-F7D4E264-21B7-4161-BE61-117D63548911Q38876299-A7AFA5E3-A7F3-44E5-8F47-3C6EAEC00C76Q39252075-8FC599E7-F0B8-4169-9113-3828DDAAE007Q39456475-D67ACA62-8601-4EC9-AC01-FE52E51EF5CCQ40396199-1481CB54-225B-4015-81BA-16FBEF8D84FFQ40918265-F1B70F6B-9268-43D2-812D-538C6B378630Q41565048-9C5B928A-DBA2-4721-A38A-206CCE2D4426Q42269229-37A38ECB-FA4C-4333-884B-90490392B0B1Q44176935-6857956D-B793-4E21-8EE5-32666C58112D
P2860
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1981
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
@en
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
@nl
type
label
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
@en
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
@nl
prefLabel
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
@en
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
@nl
P2093
P2860
P356
P1476
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
@en
P2093
C M Asplin
J P Palmer
T L Paquette
P2860
P304
P356
10.1172/JCI110251
P407
P577
1981-07-01T00:00:00Z